Investors' belief in strong earnings growth outperforming the market may explain the high P/E ratio. However, the company's weaker earnings trends and the market's expected 42% growth could risk a share price decline, lowering the P/E ratio.
PKU HealthCareLtd's weak ROE and lower-than-industry-average net income growth are concerning. Despite the company's high rate of profit retention, its low rate of return is likely hampering its earnings growth.
北大医药股票讨论区
暂无评论